Back

Levels of thyroid-stimulating hormone within the normal range and risk of major adverse cardiovascular events in non-ischemic dilated cardiomyopathy patients with severe left ventricular dysfunction

25 August 2018 (11:00 - 16:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Chronic heart failure – Pathophysiology and mechanisms Heart Failure with Reduced Ejection Fraction (HFrEF) ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Xiaofei Li

Fuwai Hospital, CAMS and PUMC, Beijing (China)

15 More presentations in this session

Presentation thumbnail
Professor H. Wang (Omaha, US)
Abstract
Presentation thumbnail
Professor Z. Zhang (Shanghai, CN)
Abstract
Presentation thumbnail
Doctor D. Benz (Zurich, CH)
Abstract
Presentation thumbnail
Doctor V. Melenovsky (Prague, CZ)
Abstract Slides
Presentation thumbnail
Doctor A. Tamura (Osaka, JP)
Abstract

Access the full session

Session thumbnail
Poster Session 1 - Chronic heart failure – Pathophysiology and mechanisms

The Event

Event poster

ESC Congress 2018

25 August 2018 11:00 CET
You may be interested in
thumbnail
Webinar
Advanced heart failure therapy in HF patients with preserved and mildly reduced ejection fraction
thumbnail
Congress Session
Meet the Experts: summation of the science - treatment of chronic heart failure in 2023
thumbnail
Congress Session
Transforming heart failure care: unlocking new pathways

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources